The store will not work correctly when cookies are disabled.
N-(3-Pyridin-2-yl-isoquinolin-1-yl)-pyrimidine-2-carboxamidine
ID: ALA148386
PubChem CID: 44363654
Max Phase: Preclinical
Molecular Formula: C19H14N6
Molecular Weight: 326.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: N=C(Nc1nc(-c2ccccn2)cc2ccccc12)c1ncccn1
Standard InChI: InChI=1S/C19H14N6/c20-17(19-22-10-5-11-23-19)25-18-14-7-2-1-6-13(14)12-16(24-18)15-8-3-4-9-21-15/h1-12H,(H2,20,24,25)
Standard InChI Key: TYZFLLSZKCLELZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
4.7042 -4.7250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7042 -5.5500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4250 -4.3125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4250 -5.9625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4250 -3.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4250 -6.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9917 -4.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7042 -3.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9917 -3.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7042 -7.1917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1375 -7.1917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1292 -3.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8500 -3.4792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1375 -5.5500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4250 -8.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1417 -8.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7042 -8.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2792 -3.0750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2792 -4.7250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5625 -3.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1292 -2.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5667 -3.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5542 -2.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5667 -4.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8375 -1.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 2 0
4 2 1 0
5 3 1 0
6 4 1 0
7 1 1 0
8 9 1 0
9 7 2 0
10 6 2 0
11 6 1 0
12 5 1 0
13 12 2 0
14 4 2 0
15 16 1 0
16 11 2 0
17 10 1 0
18 9 1 0
19 7 1 0
20 13 1 0
21 12 1 0
22 24 1 0
23 25 1 0
24 19 2 0
25 21 2 0
8 5 2 0
22 18 2 0
15 17 2 0
23 20 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 326.36 | Molecular Weight (Monoisotopic): 326.1280 | AlogP: 3.52 | #Rotatable Bonds: 3 |
Polar Surface Area: 87.44 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.10 | CX LogP: 3.51 | CX LogD: 3.51 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.44 | Np Likeness Score: -0.75 |
References
1. de Zwart MA, van der Goot H, Timmerman H.. (1989) Synthesis and copper-dependent antimycoplasmal activity of 1-amino-3-(2-pyridyl)isoquinoline derivatives. 2. Amidines., 32 (2): [PMID:2913309] [10.1021/jm00122a033] |